Shares of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the eleven research firms that are presently covering the stock, ...

KBC Group NV increased its position in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM – Free Report) by 78.2% during the 4th ...

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Oric Pharmaceuticals (ORIC – Research Report) ...

In recent developments on Wall Street, Rhythm Pharmaceuticals (NASDAQ:RYTM) received an Equal-Weight recommendation from Morgan Stanley on Tuesday. The investment bank has set a ...

After hours: February 13 at 5:40:21 PM EST Loading Chart for RYTM ...

Using artificial intelligence, computers can watch surgeons perform operations and then write post-surgical operative notes ...

Featured here, the Cash Flow Statement for Rhythm Pharmaceuticals Inc, showing the changes in the company's cash and cash equivalents, broken down to operating, investing and financing activities ...

A recent pause in U.S. sales of Varipulse is hampering the company’s bid to catch up in one of the industry’s fastest-growing ...

Anthos Therapeutics, based in Cambridge, has a drug in late-stage clinical trials aimed at preventing strokes and blood clots ...

We recently published a list of the 10 Best Medical Device Stocks To Buy According to Hedge Funds. In this article, we are ...

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Irhythm Technologies (IRTC – Research Report), Vir ...

Novartis AG agreed to buy US biotech Anthos Therapeutics for as much as $3.1 billion to gain a preventative stroke medicine ...